New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity

O. S. Weislow, Rebecca Kiser, Donald L. Fine, John P. Bader(National Institutes of Health), Robert H. Shoemaker(National Institutes of Health), Michael R. Boyd(National Cancer Institute)
JNCI Journal of the National Cancer Institute
April 19, 1989
Cited by 691

Abstract

Journal Article New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity Get access Owen S. Weislow, Owen S. Weislow Search for other works by this author on: Oxford Academic PubMed Google Scholar Rebecca Kiser, Rebecca Kiser Search for other works by this author on: Oxford Academic PubMed Google Scholar Donald L. Fine, Donald L. Fine Search for other works by this author on: Oxford Academic PubMed Google Scholar John Bader, John Bader Search for other works by this author on: Oxford Academic PubMed Google Scholar Robert H. Shoemaker, Robert H. Shoemaker Search for other works by this author on: Oxford Academic PubMed Google Scholar Michael R. Boyd Michael R. Boyd Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 81, Issue 8, 19 April 1989, Pages 577–586, https://doi.org/10.1093/jnci/81.8.577 Published: 19 April 1989 Article history Received: 12 January 1989 Accepted: 23 January 1989 Published: 19 April 1989


Related Papers

No related papers found

Powered by citation graph analysis